Upregulation of lipogenic genes in CCl4-treated hepatocytes and in the liver of CCl4-administered rats were attenuated by ILF-RE, suggesting that ILF-RE potentially ameliorates CCl4-induced hepatic steatosis by inhibiting lipogenesis (Figure 7B and Figure 9B). The gene discussed is FOXK2; the disease is fatty liver disease.